Physician profile
Robert John Bohinski
NPI 1306876172
$1,280.35
in general payments reported to CMS, 2019-2025
11 companies · $18.81 in 2025
The $18.81 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $186 · 2021: $461 · 2022: $174 · 2023: $196 · 2024: $22.36 · 2025: $18.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $344.50 | 2021-2022 | |
| Medtronic USA, INC. | $303.41 | 2019-2020 | |
| Depuy Synthes Sales INC. | $299.98 | 2019-2023 | Fibergraft Bg Morsels |
| Nuvasive, INC. | $167.17 | 2021 | |
| Innovasis INC | $45.05 | 2023 | |
| Zimvie INC. | $23.44 | 2023 | |
| Boston Scientific Corporation | $22.36 | 2024 | Wavewriter Alpha Prime 16 |
| Zimmer Biomet Holdings, INC. | $21.62 | 2019 | |
| Nevro Corp. | $21.02 | 2019 | |
| Highridge Medical LLC | $18.81 | 2025 | Invizia |
| Orthofix Medical, INC. | $12.99 | 2023 | M6-C, Newbridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bohinski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.